By
Ahmed El Sherif
08:42 am
February 23, 2021 Two UAE-based health companies have partnered with Canada’s Laipac Technology to launch the “world’s first” artificial intelligence (AI)-powered rapid COVID-19 antigen test.
YAS Pharmaceuticals and Pure Health will be working with the Ontario-based Internet of Medical Things (IoMT) specialist to provide an “intelligent and innovative way to deploy technologies to better protect the health of.
Editor s Pick
Credit: Laipac Technology
Two UAE-based health companies have partnered with Canada’s Laipac Technology to launch the “world’s first” artificial intelligence (AI)-powered rapid COVID-19 antigen test.
YAS Pharmaceuticals and Pure Health will be working with the Ontario-based Internet of Medical Things (IoMT) specialist to provide an “intelligent and innovative way to deploy technologies to better protect the health of people across the region,” Laipac announced in a statement.
Currently being showcased at the 2021 International Defence Exhibition & Conference (IDEX) in Abu Dhabi, the LooK SPOT features a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasal swabs. The cassette is then connected to a smartphone in order for a special application to scan for signs of COVID-19.